Latozinemab (Anti-Sortilin / SORT1)

製品コード：A2920         Batch: A292002

印刷

Latozinemab (anti-Sortilin / SORT1) is a recombinant humanized anti-Sortilin monoclonal antibody. Latozinemab has the potential for progranulin gene (GRN) mutations causative of frontotemporal dementia (FTD) (FTD-GRN) research. MW: 146.28 KD.

製品説明

CAS No. 2376132-27-1
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 6.711mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Tumor-associated tissue-resident macrophages drive pancreatic cancer progression through IGF1-IGF1R signaling [ bioRxiv, May 12, 2026, 27]

人間や獣医の診断であるか治療的な使用のためにでない。